The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with (99m)Tc-Tilmanocept SPECT

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancers and is not eligible for hormone and anti-HER2 therapies. Identifying therapeutic targets and associated biomarkers in TNBC is a clinical challenge to improve patients’ outcome and management. High infiltration of C...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchard, Alexanne, Sikner, Hugo, Baverel, Valentin, Garnier, Anaïs-Rachel, Monterrat, Marie, Moreau, Mathieu, Limagne, Emeric, Garrido, Carmen, Kohli, Evelyne, Collin, Bertrand, Bellaye, Pierre-Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699502/
https://www.ncbi.nlm.nih.gov/pubmed/34943901
http://dx.doi.org/10.3390/cells10123393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699502/
https://www.ncbi.nlm.nih.gov/pubmed/34943901
http://dx.doi.org/10.3390/cells10123393

Ejemplares similares